Oct. 7: A Virtual Conversation with Carl Zimmer, Science Journalist at The New York Times

President Trump has COVID-19. Now what?

Wednesday, October 7, 7 pm ET on Zoom

  • When did the President become sick? What is his prognosis?
  • What is a superspreader event? 
  • What is the scientific evidence for the medical regimen he is on?

After the announcement on Friday, October 2 that President Donald Trump tested positive for COVID-19, the White House said that was injected with an experimental antibody cocktail by the White House physician. In addition, he was taking remdesivir, an antiviral drug shown to modestly help hospitalized COVID-19 patients. The President was also taking vitamin D, zinc, melatonin and Pepcid. He reportedly had mild COVID-19 symptoms, including fever and congestion and was then transferred to Walter Reed National Military Medical Center. 

On Wednesday, October 7, Science Writers in New York invites you to join us on Zoom for a conversation with SWINY co-chair David Levine (@dlloydlevine) and New York Times science journalist Carl Zimmer (@carlzimmer). Carl will discuss the onset of President Trump’s illness, his medical regimen, his prognosis and explain what superspreader events are.

Read more about the President’s treatment.

Carl began writing about science for The New York Times in 2004, where he now writes his weekly column “Matter.” He has won many awards for his work, including the Stephen Jay Gould Prize, awarded by the Society for the Study of Evolution to recognize individuals whose sustained efforts have advanced public understanding of evolutionary science. Carl is the author of 13 books about science, including his most recent, She Has Her Mother’s Laugh: The Power, Perversions, and Potential of Heredity.

Wednesday, October 7
7 to 8 pm ET

This entry was posted in Events and tagged , , . Bookmark the permalink.